FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileWisdomTree BioRevolution Fund
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
WDNA
WisdomTree BioRevolution Fund ETF AnalysisComprehensive ETF analysis for WisdomTree BioRevolution Fund (WDNA) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisWDNA
WDNA
WisdomTree BioRevolution Fund
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
WDNA
  1. Home
  2. Screener
  3. WisdomTree BioRevolution FundWDNAETF
WisdomTree BioRevolution Fund Logo

WisdomTree BioRevolution Fund

ETF
🇺🇸WDNA•CBOE•Sector Equity

Your view on WDNA

WisdomTree BioRevolution Fund Logo

WisdomTree BioRevolution Fund

ETFWisdomTree
🇺🇸WDNA•CBOE•Sector Equity
AUM (USD)$4.73M
Expense Ratio0.45%
Yield (TTM)3.69%
Holdings99

Sentiment

—

AUM (USD)

$4.73M

Expense Ratio

0.45%

Yield (TTM)

3.69%

Holdings

99

Sentiment

—
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

WisdomTree BioRevolution Fund (WDNA) is a Sector Equity fund from WisdomTree, listed since 2021, with $4.7M in assets under management, a 0.45% expense ratio and a NAV of $22.52 USD.

Overview for WisdomTree BioRevolution Fund

Fund Type
ETF
Fund Issuer
WisdomTree
Asset Class
Sector Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
June 3, 2021
Domicile
US
Website
wisdomtree.com/investments/etfs/megatrends/wdna
Fund Type
ETF
Fund Issuer
WisdomTree
Asset Class
Sector Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
June 3, 2021
Domicile
US
Website
wisdomtree.com/investments/etfs/megatrends/wdna
Fund Type
ETF
Fund Issuer
WisdomTree
Asset Class
Sector Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
June 3, 2021
Domicile
US
Website
wisdomtree.com/investments/etfs/megatrends/wdna

About this fund

This fund primarily aims to meet its investment goals by employing a representative sampling method. This means it selects a portion of the securities from its benchmark index, ensuring that this smaller selection closely reflects the broader index's risk profile, expected return…

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Sector Equity

Expense Ratio

0.45%

Yield (TTM)

3.69%

AUM

$4.73M

Fund Details

NAV$22.52 USD
Holdings99
Average Volume2.5K
Inception DateJune 3, 2021
Asset ClassSector Equity
Fund IssuerWisdomTree
DomicileUS
ISINUS97717Y6187
CUSIP97717Y618
NAV CurrencyUSD

Expense Ratio

0.45%

Dividend Yield (TTM)

3.69%

Assets Under Management

$4.73M

NAV

$22.52 USD

Holdings

99

Average Volume

2.5K

Inception Date

June 3, 2021

Asset Class

Sector Equity

Fund Issuer

WisdomTree

Domicile

US

ISIN

US97717Y6187

CUSIP

97717Y618

NAV Currency

USD

Expense Ratio

0.45%

Dividend Yield (TTM)

3.69%

Assets Under Management

$4.73M

NAV

$22.52 USD

Holdings

99

Average Volume

2.5K

Inception Date

June 3, 2021

Asset Class

Sector Equity

Fund Issuer

WisdomTree

Domicile

US

ISIN

US97717Y6187

CUSIP

97717Y618

NAV Currency

USD

Distributions · last 12 months

Annual · 1 payment

Ex-datePaidAmount
Dec 26, 2025Dec 30, 2025$0.7705
Total, 12 months$0.77 a share

Dividend yield (TTM) 3.69% = $0.77 paid per share in the 12 months to Nov 20, 2026 ÷ the $20.87 price. Past distributions; future payments can differ.

Data last updated: Nov 18, 2026, 08:12 AM

Sectors

How the fund's assets are split across sectors.

4 sectors
  • 1Healthcare
    93.1%
  • 2Basic Materials
    3.5%
  • 3Consumer Defensive
    1.8%
  • 4Financial Services
    1.6%

Top sector

Healthcare

Top weight

93.1%

Top 3 weight

98.4%

Holdings

The securities the fund owns, by weight.

90 positions
1TEMTempus Ai Inc
3.74%
2LLYEli Lilly & Co
3.64%
3MRNAModerna Inc
3.38%
4TWSTTwist Bioscience Corp
3.00%
5IMNMImmunome Inc
2.92%
6TMOThermo Fisher Scientific Inc
2.56%
7NTRANatera Inc
2.38%
8STOKStoke Therapeutics Inc
2.33%
9UTHRUnited Therapeutics Corp
2.14%
10TXG10X Genomics Inc-Class A
1.92%
11VRTXVertex Pharmaceuticals Inc
1.90%
12AMGNAmgen Inc
1.81%
13GILDGilead Sciences Inc
1.81%
14CGONCg Oncology Inc
1.78%
15ROIVRoivant Sciences Ltd
1.75%

Concentration

Total Holdings90
Top 10 Weight28.01%
Top HoldingTEM
Top Weight3.74%
1TEMTempus Ai Inc
3.74%
2LLYEli Lilly & Co
3.64%
3MRNAModerna Inc
3.38%
4TWSTTwist Bioscience Corp
3.00%
5IMNMImmunome Inc
2.92%
6TMOThermo Fisher Scientific Inc
2.56%
7NTRANatera Inc
2.38%
8STOKStoke Therapeutics Inc
2.33%
9UTHRUnited Therapeutics Corp
2.14%
10TXG10X Genomics Inc-Class A
1.92%
11VRTXVertex Pharmaceuticals Inc
1.90%
12AMGNAmgen Inc
1.81%
13GILDGilead Sciences Inc
1.81%
14CGONCg Oncology Inc
1.78%
15ROIVRoivant Sciences Ltd
1.75%

Total Holdings

90

Top 10 Weight

28.01%

Top Holding

TEM

Top Weight

3.74%

1TEMTempus Ai Inc
3.74%$181.1K
2LLYEli Lilly & Co
3.64%$176.0K
3MRNAModerna Inc
3.38%$163.7K
4TWSTTwist Bioscience Corp
3.00%$145.2K
5IMNMImmunome Inc
2.92%$141.5K
6TMOThermo Fisher Scientific Inc
2.56%$123.7K
7NTRANatera Inc
2.38%$115.3K
8STOKStoke Therapeutics Inc
2.33%$112.5K
9UTHRUnited Therapeutics Corp
2.14%$103.4K
10TXG10X Genomics Inc-Class A
1.92%$92.8K
11VRTXVertex Pharmaceuticals Inc
1.90%$91.9K
12AMGNAmgen Inc
1.81%$87.5K
13GILDGilead Sciences Inc
1.81%$87.5K
14CGONCg Oncology Inc
1.78%$86.2K
15ROIVRoivant Sciences Ltd
1.75%$84.4K

Total Holdings

90

Top 10 Weight

28.01%

Top Holding

TEM

Top Weight

3.74%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on20 funds
FundAsset classExpense ratioAssetsHoldings
WDNAWisdomTree BioRevolution FundThis fundSector Equity0.45%$5M99

Comparable funds

  • BWETBreakwave Tanker Shipping ETFEquity3.50%$70M10
  • DESKVanEck Office and Commercial REIT ETFMulti-Asset0.51%$5M26
  • EGLEGlobal X - S&P 500 U.S. Revenue Leaders ETFEquity0.19%$2M371
  • FGSIFT Vest Growth Strength & Target Income ETFMulti-Asset0.85%$2M51
  • JETDMAX Airlines -3X Inverse Leveraged ETNsEquity0.95%$4M0
  • LGCFThemes US Cash Flow Champions ETFEquity0.29%$2M76
  • PEVCPacer PE/VC ETFEquity0.85%$2M213
  • SPAMThemes Cybersecurity ETFEquity0.35%$8M36

More WisdomTree ETFs

  • DXJWisdomTree Japan Hedged Equity FundInternational Equity0.48%$7.0B441
  • EESWisdomTree U.S. SmallCap Earnings FundUS Equity0.38%$688M917
  • ELDWisdomTree Emerging Markets Local Debt FundFixed Income0.55%$130M224
  • EMCBWisdomTree Emerging Markets Corporate Bond FundFixed Income0.60%$100M173
  • EMMFWisdomTree Emerging Markets Multifactor FundEmerging Markets Equity0.48%$178M238
  • EPIWisdomTree India Earnings FundEmerging Markets Equity0.84%$1.8B413
  • EPSWisdomTree U.S. Earnings 500 FundUS Equity0.08%$1.6B503
  • EUDGWisdomTree Europe Quality Dividend Growth FundInternational Equity0.58%$67M225
  • EZMWisdomTree U.S. MidCap Earnings FundUS Equity0.38%$944M556
  • GCCWisdomTree Enhanced Commodity Strategy FundAlternatives0.55%$208M37
  • GDEWisdomTree Efficient Gold Plus Equity Strategy FundAlternatives0.20%$378M502
  • GDMNWisdomTree Efficient Gold Plus Gold Miners Strategy FundAlternatives0.45%$152M70
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.

News

Latest Market News

News

Latest Market News